Molecular Mechanism of Lymphoma
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cell Proliferation and Division".
Deadline for manuscript submissions: closed (15 March 2023) | Viewed by 3604
Special Issue Editor
Interests: leukemia; lymphoma; targeted therapy; molecular diagnostics; high throughput genomics; transcriptomics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The recent improvements in the knowledge of the molecular pathogenesis of malignant lymphoma have offered a new rational basis for innovative approaches as far as both diagnostics and therapies are concerned. However, on the other hand, recent studies, especially those based on next-generation sequencing, also highlighted the complexity of these disorders. Like opening Pandora’s box, a tremendous amount of information was released, needing more and more investigations to fully understand the consequences of specific lesions as well as the potential interaction across affected proteins and pathways. Furthermore, the alteration of cellular metabolism has emerged as a prominent character in lymphoma development and progression.
This Special Issue aims to provide new concepts and ideas on the pathobiology of human lymphomas in terms of pathology, genetics, cell metabolism and biomarker discovery. New experimental findings (research articles) as well as reviews (the latter requiring preliminary contact with the Editor before submission), communications, and editorials are acceptable and will be considered.
The objective is to eventually favor the translation of genomic and pre-clinical findings into concrete benefits for lymphoma patients.
Prof. Dr. Pier Paolo Piccaluga
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- lymphoma
- pathology of lymphoma
- tumor metabolism
- molecular pathogenesis
- pathogens driven lymphoma
- molecular diagnosis
- targeted therapy
